DIM
Diindolylmethane · Metabolic
A broccoli-derived compound sold for "estrogen balance" on largely preclinical grounds.
What it is
Diindolylmethane, a compound your stomach makes from a broccoli precursor, sold for "estrogen balance", acne and hormonal support. It is a good test of a supplement claim: the mechanism is real and specific, and the human outcome evidence is almost entirely missing.
How it works
DIM shifts how the body metabolises estrogen, nudging it toward 2-hydroxy metabolites rather than 16-hydroxy ones. That shift is genuinely measurable in urine. The leap the marketing makes is that a different metabolite ratio means better health, hormone balance, or clearer skin, and that leap is where the evidence stops.
Which form to buy
Raw DIM is poorly absorbed; most credible products use an enhanced-delivery formulation.
Necessary if using it at all.
Poor absorption limits what reaches you.
Cheap and largely wasted.
Converts to DIM in stomach acid, but unpredictably and into multiple products.
Less predictable than DIM itself.
Broccoli, cabbage and Brussels sprouts supply the precursor with everything else those foods bring.
The version with an actual health-outcome literature behind it.
What it actually does, graded
Measurably demonstrated in human studies, the one thing DIM clearly does.
A very common selling point with essentially no controlled trial support.
"Estrogen dominance" is not a defined clinical diagnosis, and no trial shows DIM improves symptoms attributed to it.
Cell and animal work drives the interest; human prevention evidence does not exist.
Popular in that community, unsupported by trials, and not a substitute for medical management.
Pros and cons
- A real, measurable biological effect on estrogen metabolism
- Derived from foods with genuinely good health evidence
- Nearly every consumer claim rests on the metabolite shift rather than any outcome
- It can turn urine orange, startling, harmless
- Interferes with hormonal medication in ways that are poorly mapped
- Headaches and GI upset are commonly reported
What to expect
- Urine may turn orange, harmless and the most reliable effect people notice.
- The metabolite shift is measurable in a lab, not in how you feel.
Interactions
Is it for you?
- Curiosity about estrogen metabolism, with expectations set to "a lab measurement changes"
- You want it for acne or "hormone balance", neither has trial support
- You take hormonal contraception, an unproven benefit against a theoretical interaction is a poor trade
Who should avoid it
- Anyone on hormone-directed cancer therapy such as tamoxifen, without oncology input
Research on this supplement
Papers about this supplement, not proof of the claims above. A title says what was studied, which is sometimes a negative result or a different question entirely.
- 3,3-Diindolylmethane (DIM): a nutritional intervention and its impact on breast density in healthy BRCA carriers. A prospective clinical trial
- A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen
- Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy
What the evidence says
DIM does shift estrogen metabolism toward 2-hydroxy metabolites, which is measurable and real. Whether that shift produces any benefit (for hormonal acne, for menopausal symptoms, for cancer risk) is where the evidence runs out; most work is cell, animal or small mechanistic human studies rather than outcome trials.
What studies used
Studies commonly used 100-300 mg/day. Published studies had not established a preferred timing.
Reported from published studies and product labelling — a record of what was used in research, not a recommendation. What is right for you is a conversation with a clinician.
Watch out for
- A randomised trial in women taking tamoxifen found DIM REDUCED tamoxifen metabolite levels including endoxifen, a genuine interaction with a cancer therapy, and the most important thing on this entry
- It is not an aromatase inhibitor and does not act like one, despite frequently being sold beside them
- Commonly turns urine orange or brown, harmless but alarming if unexpected
Evidence base
established literature
Strong human evidence: either a phase 3 or 4 trial report alongside review-level evidence, or ten or more randomised controlled trial reports.
This letter measures how much human research exists, not whether it works for you — the tier above (Limited) is the read on quality.
Research (12)
- Exosome-sheathed porous silica nanoparticle-mediated co-delivery of 3,3'-diindolylmethane and doxorubicin attenuates cancer stem cell-driven EMT in triple negative breast cancerJ Nanobiotechnology · 2024
- 3, 3'-diindolylmethane enhances macrophage efferocytosis and subsequently relieves visceral pain via the AhR/Nrf2/Arg-1-mediated arginine metabolism pathwayPhytomedicine · 2023
- Benzo[a]pyrene toxicokinetics in humans following dietary supplementation with 3,3'-diindolylmethane (DIM) or Brussels sproutsToxicol Appl Pharmacol · 2023
- Decreased mitochondrial translation confers 3,3'-Diindolylmethane resistance to Schizosaccharomyces pombeBiochem Biophys Res Commun · 2024
- Cellular and Molecular Mechanisms of 3,3'-Diindolylmethane in Gastrointestinal CancerInt J Mol Sci · 2016
- General Synthesis of Unsymmetrical 3,3'-(Aza)diindolylmethane DerivativesJ Org Chem · 2018
- The impact of 3,3'-diindolylmethane on estradiol and estrogen metabolism in postmenopausal women using a transdermal estradiol patchMenopause · 2025
- 3,3'-Diindolylmethane disrupts the endoplasmic reticulum and nuclear envelope in Schizosaccharomyces pombeBiochem Biophys Res Commun · 2024
- 3,3'-Diindolylmethane Exhibits Significant Metabolism after Oral Dosing in HumansDrug Metab Dispos · 2021
- 3,3'-Diindolylmethane Ameliorates Metabolism Dysfunction-Associated Fatty Liver Disease via AhR/p38 MAPK SignalingNutrients · 2025
- 3,3'-Diindolylmethane and 1,4-dihydroxy-2-naphthoic acid prevent chronic mild stress induced depressive-like behaviors in female miceJ Affect Disord · 2022
- 3, 3'- diindolylmethane hinders IL-17A/IL-17RA interaction and mitigates imiquimod-induced psoriasiform in miceInt Immunopharmacol · 2022
Turn DIM into a plan that's yours
The info above is free. Membership makes it personal, the Coach answers questions about your exact stack, the Stack tracks it for you, and the Verified Sources shows you how to vet what you buy.
- ✓ AI Coach, ask anything about your stack. It does the dosing math, flags interactions, and tells you what to do next.
- ✓ Personal Stack, save your protocol, track it across devices, log doses, get a heads-up before a vial runs out.
- ✓ Verified Sources, the vetted reference for checking quality and sourcing, members only.
Cancel anytime · or save with $59.99/yr · Coach + Stack included